A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of BIOD-123 compared to
insulin lispro (Humalog®) when used as part of a basal-bolus regimen in patients with type 1
diabetes.